title: Heart Failure Society of South Africa (HeFSSA) perspective on the European Society of Cardiology (ESC) 2012 chronic heart failure guideline.
abstract: BACKGROUND
  The South African Heart Association (SA Heart) is an affiliate of the European Society of Cardiology (ESC). SA Heart endorses ESC treatment guidelines with modification to suit local circumstances. The Heart Failure Society of South Africa (HeFSSA) is a special interest group of SA Heart. This guideline has been compiled on behalf of the HeFSSA and is based on the ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The focus is on heart failure with reduced ejection fraction (HF-REF) (i.e. ejection fraction <50%). We have recommended interventions in symptomatic patients with HF-REF in general to clarify the 'grey area' between the ESC guidelines definition of REF (<50%) and the predefined ejection fraction used in randomised heart failure trials (<35%).
  
  
  OBJECTIVE
  To highlight new changes in the diagnosis and treatment of chronic heart failure with particular emphasis on areas that are relevant to SA.
  
  
  CONCLUSIONS
  Randomised clinical trials are a crucial, but not the only, guide in treating HF-REF patients. There always remain questions that are unanswered and groups of patients not studied, so prudent clinical decisions are required.
authors.affiliation: Heart Failure Society of South Africa. info@heffsa.org.
authors.forename: M T
authors.initials: MT
authors.lastname: Mpe
authors.forename: E Q
authors.initials: EQ
authors.lastname: Klug
authors.forename: K S
authors.initials: KS
authors.lastname: Silwa
authors.forename: J
authors.initials: J
authors.lastname: Hitzeroth
authors.forename: D A
authors.initials: DA
authors.lastname: Smith
mesh_terms: D000465:Algorithms; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002304:Cardiac Pacing, Artificial; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003663:Decision Trees; D003935:Diagnostic Techniques, Cardiovascular; D004232:Diuretics / Q000627:therapeutic use; D004554:Electric Countershock; D005060:Europe; D006333:Heart Failure / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D006801:Humans; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D013019:South Africa
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D002317:Cardiovascular Agents; D004232:Diuretics